Cucurbitacin S

Cucurbitacin s is a lipid of Sterol Lipids (ST) class. The involved functions are known as establishment and maintenance of localization and nitric oxide biosynthetic process.

Cross Reference

Introduction

To understand associated biological information of Cucurbitacin S, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Cucurbitacin S?

There are no associated biomedical information in the current reference collection.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with Cucurbitacin S

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Cucurbitacin S?

There are no associated biomedical information in the current reference collection.

What functions are associated with Cucurbitacin S?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Cucurbitacin S?

There are no associated biomedical information in the current reference collection.

What genes are associated with Cucurbitacin S?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with Cucurbitacin S?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Cucurbitacin S

Download all related citations
Per page 10 20 50 100 | Total 106
Authors Title Published Journal PubMed Link
pmid:28946127
pmid:28171685
pmid:28167007
pmid:27061415
pmid:26856457
pmid:26780083
pmid:26566075
pmid:26503558
pmid:25908626
pmid:25761128
pmid:25760384
pmid:24682977
pmid:24462673
pmid:24360122
pmid:28274497
pmid:28240721
pmid:
Guo J et al. The anti-melanoma efficiency of the intratumoral injection of cucurbitacin-loaded sustained release carriers: in situ-forming implants. 2015 AAPS PharmSciTech pmid:25609378
Wang WD et al. ANTITUMOR AND APOPTOTIC EFFECTS OF CUCURBITACIN A IN A-549 LUNG CARCINOMA CELLS IS MEDIATED VIA G2/M CELL CYCLE ARREST AND M-TOR/PI3K/AKT SIGNALLING PATHWAY. 2017 Afr J Tradit Complement Altern Med pmid:28573224
Theis N et al. Attracting mutualists and antagonists: plant trait variation explains the distribution of specialist floral herbivores and pollinators on crops and wild gourds. 2014 Am. J. Bot. pmid:25156980
Yang PQ et al. Cucurbitacin contents in Hemsleya dolichocarpa. 1991 Am. J. Chin. Med. pmid:1897490
Chen X et al. Biological activities and potential molecular targets of cucurbitacins: a focus on cancer. 2012 Anticancer Drugs pmid:22561419
Henrich CJ et al. Effects of cucurbitacins on cell morphology are associated with sensitization of renal carcinoma cells to TRAIL-induced apoptosis. 2012 Apoptosis pmid:21928090
Tannin-Spitz T et al. Cucurbitacin glucosides: antioxidant and free-radical scavenging activities. 2007 Biochem. Biophys. Res. Commun. pmid:17942079
Witkowski A et al. Inhibition of the biosynthesis of deoxyribonucleic acid, ribonucleic acid and protein in HeLa S3 cells by cucurbitacins, glucocorticoid-like cytotoxic triterpenes. 1984 Biochem. Pharmacol. pmid:6546879
Witkowski A and Konopa J Binding of the cytotoxic and antitumor triterpenes, cucurbitacins, to glucocorticoid receptors of HeLa cells. 1981 Biochim. Biophys. Acta pmid:6894552
Patel SK et al. Roles of nonpolar and polar intermolecular interactions in the improvement of the drug loading capacity of PEO-b-PCL with increasing PCL content for two hydrophobic Cucurbitacin drugs. 2009 Biomacromolecules pmid:19655789
Patel SK et al. Prediction of the solubility of cucurbitacin drugs in self-associating poly(ethylene oxide)-b-poly(alpha-benzyl carboxylate epsilon-caprolactone) block copolymer with different tacticities using molecular dynamics simulation. 2010 Biomaterials pmid:19796808
Patel SK et al. Molecular dynamics study of the encapsulation capability of a PCL-PEO based block copolymer for hydrophobic drugs with different spatial distributions of hydrogen bond donors and acceptors. 2010 Biomaterials pmid:19962756
Bai M et al. Development and validation of an LC-ESI-MS/MS method for the quantitation of hemslecin A in rhesus monkey plasma and its application in pharmacokinetics. 2014 Biomed. Chromatogr. pmid:24132644
Bartalis J and Halaweish FT In vitro and QSAR studies of cucurbitacins on HepG2 and HSC-T6 liver cell lines. 2011 Bioorg. Med. Chem. pmid:21459003
Ramalhete C et al. New potent P-glycoprotein modulators with the cucurbitane scaffold and their synergistic interaction with doxorubicin on resistant cancer cells. 2009 Bioorg. Med. Chem. pmid:19733087
Guo RH et al. Synthesis of hemslecin A derivatives: a new class of hepatitis B virus inhibitors. 2013 Bioorg. Med. Chem. Lett. pmid:23385212
Chen CH et al. Identification of cucurbitacins and assembly of a draft genome for Aquilaria agallocha. 2014 BMC Genomics pmid:25005802
Kuo TC et al. The effect of red light and far-red light conditions on secondary metabolism in agarwood. 2015 BMC Plant Biol. pmid:26067652
Boykin C et al. Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation. 2011 Br. J. Cancer pmid:21304528
Ren S et al. Anti-proliferative effect of 23,24-dihydrocucurbitacin F on human prostate cancer cells through induction of actin aggregation and cofilin-actin rod formation. 2012 Cancer Chemother. Pharmacol. pmid:22814677
Jayaprakasam B et al. Anticancer and antiinflammatory activities of cucurbitacins from Cucurbita andreana. 2003 Cancer Lett. pmid:12445672
GALLILY R et al. Further studies on the antitumor effect of cucurbitacins. 1962 Cancer Res. pmid:13946249
Gabrielsen M et al. Cucurbitacin covalent bonding to cysteine thiols: the filamentous-actin severing protein Cofilin1 as an exemplary target. 2013 Cell Commun. Signal pmid:23945128
Dinan L et al. Assessment of natural products in the Drosophila melanogaster B(II) cell bioassay for ecdysteroid agonist and antagonist activities. 2001 Cell. Mol. Life Sci. pmid:11289314
Himeno E et al. Structures of cayaponosides A, B, C and D, glucosides of new nor-cucurbitacins in the roots of Cayaponia tayuya. 1992 Chem. Pharm. Bull. pmid:1464123
Kawahara N et al. Two new cucurbitacin glucosides, opercurins A and B, from the Brazilian folk medicine "Buchinha" (Luffa operculata). 2004 Chem. Pharm. Bull. pmid:15305007
Shaw JT and Hummel HE A monitoring trap for Diabrotica virgifera virgifera and D. barberi adults lured with a poisoned cucurbitacin bait. 2003 Commun. Agric. Appl. Biol. Sci. pmid:15149093
Ríos JL et al. Cucurbitacins as inducers of cell death and a rich source of potential anticancer compounds. 2012 Curr. Pharm. Des. pmid:22443631
Ayyad SE et al. In vitro and in vivo study of cucurbitacins-type triterpene glucoside from Citrullus colocynthis growing in Saudi Arabia against hepatocellular carcinoma. 2012 Environ. Toxicol. Pharmacol. pmid:22245841
Hira SK et al. Downregulation of endogenous STAT3 augments tumoricidal activity of interleukin 15 activated dendritic cell against lymphoma and leukemia via TRAIL. 2014 Exp. Cell Res. pmid:25139620
Attard EG and Scicluna-Spiteri A Ecballium elaterium: an in vitro source of cucurbitacins. 2001 Fitoterapia pmid:11163940
Kirschman JC and Suber RL Recent food poisonings from cucurbitacin in traditionally bred squash. 1989 Food Chem. Toxicol. pmid:2792979
Yang K et al. [Clinical application of anticancer nanoparticles targeting metastasis foci of cervical lymph nodes in patients with oral carcinoma]. 2003 Hua Xi Kou Qiang Yi Xue Za Zhi pmid:14732978